Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion support in acute leukemias

I J Webb1, K C Anderson

  • 1Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

Seminars in Oncology
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training.

mAbs·2025
Same author

Retraction Note: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide.

Leukemia·2024
Same author

Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials.

Seminars in hematology·2023
Same author

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2019
Same author

Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma.

Leukemia·2018
Same author

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Leukemia·2017
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Patients with leukemia undergoing treatment often require blood transfusions. This review covers transfusion guidelines and potential complications like immune reactions and infections.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Oncohematology

Background:

  • Patients with acute myeloid leukemia and acute lymphocytic leukemia require frequent blood product transfusions for cytopenias during treatment.
  • These transfusions place patients at a higher risk for transfusion-associated complications.

Purpose of the Study:

  • To review the indications for red blood cell and platelet transfusions in leukemia patients.
  • To discuss the incidence and prevention strategies for immunohematologic and infectious complications following multiple blood component transfusions.

Main Methods:

  • Literature review of transfusion indications.
  • Analysis of incidence and prevention strategies for transfusion complications.
  • Focus on immunohematologic and infectious sequelae.

Related Experiment Videos

Main Results:

  • Transfusion indications for red blood cells and platelets are established.
  • Immunohematologic and infectious complications are significant risks.
  • Preventive strategies are crucial for managing transfusion risks.

Conclusions:

  • Leukemia patients receiving multiple transfusions are prone to specific complications.
  • Adherence to transfusion guidelines and proactive management of sequelae are essential for patient care.